Virgin olive oil in preventive medicine: From legend to epigenetics

European Journal of Lipid Science and Technology

Volumn 114, Issue 4, 2012, Pages 375-388

  Caramia, Giuseppe ^a   Gori, Alessandro ^b   Valli, Enrico ^b   Cerretani, Lorenzo ^b,c  

^a Ospedale Pediatrico G Salesi   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c PIZZOLI R and S ^*  (Italy)

Author keywords

Extra virgin olive oil; Human health; Physiological mechanisms; Therapeutic

Indexed keywords

EID: 84859624125     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.201100164     Document Type: Review

References (120)

1. Sorcinelli, P., in: Flandrin, J., Montanari, M. (Eds.), Storia Dell'alimentazione, Laterza, Roma-Bari (Italy) 1997, pp. 632- 642.
2. Mazzini, I., L'uso dell'olio d'oliva nella medicina del mondo antico. Medizinhist. J. 2000, 35, 105- 126.
3. Mazzini, I., in: Flandrin, J., Montanari, M. (Eds.), Storia Dell'alimentazione, Laterza, Roma-Bari (Italy) 1997, pp. 191- 200.
4. Montanari, M., Alimentazione e Cultura nel Medioevo, Laterza, Roma-Bari (Italy) 1988.
5. Lawn, B., The Salernitan Questions, An Introduction to the History of Medieval and Renaissance Problem Literature, Clarendon Press, Oxford, UK 1963.
6. Kritchevsky, D., Dietary protein, cholesterol and atherosclerosis: A review of the early history. J. Utr. 1995, 125, 589- 593.
7. Keys, A., Parlin, R. W., Serum-cholesterol response to changes in dietary lipids. Am. J. Clin. Nutr. 1966, 19, 175- 181.
8. Fidanza, F., Puddu, V., Imbimbo, A. B., Menotti, A., Keys, A., Coronary heart disease in seven countries. VII. Five-year experience in rural Italy. Circulation 1970, 41, 63- 75.
9. Keys, A., Menotti, A., Aravanis, C., Blackburn, H. et al., The seven countries study: 2, 289 deaths in 15 years. Prev. Med. 1984, 13, 141- 154.
10. Keys, A., Aravanis, C., Blackburn, H., Buzina, R. et al., Serum cholesterol and cancer mortality in the Seven Countries Study. Am. J. Epidemiol. 1985, 121, 870- 883.
11. Keys, A., Menotti, A., Karvonen, M. J., Aravanis, C. et al., The diet and 15-year death rate in the Seven Countries Study. Am. J. Epidemiol. 1986, 124, 903- 915.
12. Menotti, A., Keys, A., Aravanis, C., Blackburn, H. et al., Seven Countries Study. First 20-year mortality data in 12 cohorts of six countries. Ann. Med. 1989, 21, 175- 179.
13. Renaud, S., de Lorgeril, M., Delaye, J., Cretan Mediterranean diet for prevention of coronary heart Disease. Am. J. Clin. Nutr. 1995, 61, 1360- 1367.
14. Trichopoulou, A., Costacou, T., Bamia, C., Trichopoulos, D., Adherence to a Mediterranean diet and survival in a Greek population. N. Engl. J. Med. 2003, 348, 2599- 2608.
15. Trichopoulou, A., Bamia, C., Trichopoulos, D., Mediterranean diet and survival among patients with coronary heart disease in Greece. Arch. Intern. Med. 2005, 165, 929- 935.
16. Pérez-Jiménez, F., Alvarez de Cienfuegos, G., Badimon, L., Barja, G. et al., International conference on the healthy effect of virgin olive oil. Eur. J. Clin. Invest. 2005, 35, 421- 424.
17. Willett, W. C., The Mediterranean diet: Science and practice. Public Health Nutr. 2006, 9, 105- 110.
18. Panagiotakos, D. B., Polystipioti, A., Papairakleous, N., Polychronopoulos, E., Long-term adoption of a Mediterranean diet is associated with a better health status in elderly people; a cross-sectional survey in Cyprus. Asia Pac. J. Clin. Nutr. 2007, 16, 331- 337.
19. Sofi, F., Cesari, F., Abbate, R., Gensini, G. F. et al., Adherence to Mediterranean diet and health status: Meta-analysis. Br. Med. J. 2008, 337, a1344.
20. Sánchez-Taínta, A., Estruch, R., Bulló, M., Gómez-Gracia, E. et al., Adherence to a Mediterranean-type diet and reduced prevalence of clustered cardiovascular risk factors in a cohort of 3, 204 high-risk patients. Eur. J. Cardiov. Prev. R 2008, 15, 589- 593.
21. Kafatos, A., Diacatou, A., Voukiklaris, G., Heart disease risk-factor status and dietary changes in the Cretan population over the past 30 years: The Seven Countries Study. Am. J. Clin. Nutr. 1997, 65, 1882- 1886.
22. de Lorgeril, M., Renaud, S., Mamelle, N., Salen, P. et al., Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994, 343, 1454- 1459.
23. de Lorgeril, M., Salen, P., Martin, J. L., Monjaud, I. et al., Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study. Circulation 1999, 99, 779- 785.
24. Kreeft, A. J., Moen, C. J., Porter, G., Kasanmoentalib, S. et al., Genomic analysis of the response of mouse models to high-fat feeding shows a major role of nuclear receptors in the simultaneous regulation of lipid and inflammatory genes. Atherosclerosis 2005, 182, 249- 257.
25. Pérez-Jiménez, F., Ruano, J., Perez-Martinez, P., Lopez-Segura, F., Lopez-Miranda, J., The influence of olive oil on human health: Not a question of fat alone. Mol. Nutr. Food Res. 2007, 51, 1199- 1208.
26. Mensink, R. P., Zock, P. L., Kester, A. D., Katan, M. B., Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins:a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 2003, 77, 1146- 1155.
27. Cerretani, L., Bendini, A., Lercker, G., Caramia, G., I composti a struttura fenolica, componenti minoritari esclusivi dell'olio extravergine di oliva e il loro ruolo salutistico. in: proceedings of the XXI Congresso Nazionale SIPPS, Siena, 2009, pp. 102- 103.
28. Pallottini, V., Martini, C., Pascolini, A., Cavallini, G. et al., Trentalance. 3-Hydroxy-3-methylglutaryl coenzyme A reductase deregulation and age-related hypercholesterolemia: A new role for ROS. Mech. Ageing Dev. 2005, 126, 845- 851.
29. Perona, J. S., Cabello-Moruno, R., Ruiz-Gutierrez, V., The role of virgin olive oil components in the modulation of endothelial function. J. Nutr. Biochem. 2006, 17, 429- 445.
30. Bendini, A., Cerretani, L., Carrasco-Pancorbo, A., Gómez-Caravaca, A. M. et al., Phenolic molecules in virgin olive oils: A survey of their sensory properties, health effects, antioxidant activity and analytical methods. An overview of the last decade. Molecules 2007, 12, 1679- 1719.
31. Ruiz-Gutiérrez, V., Muriana, F. J., Guerrero, A., Cert, A. M., Villar, J., Plasma lipids, erythrocyte membrane lipids and blood pressure of hypertensive women after ingestion of dietary oleic acid from two different sources. J. Hypertens. 1996, 14, 1483- 1490.
32. Ferrara, L. A., Raimondi, A. S., d'Episcopo, L., Guida, L. et al., Olive oil and reduced need for antihypertensive medications. Arch. Intern. Med. 2000, 160, 837- 842.
33. Esposito, K., Marfella, R., Ciotola, M., Di Palo, C. et al., Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial. JAMA 2004, 292, 1440- 1446.
34. Psaltopoulou, T., Naska, A., Orfanos, P., Trichopoulos, D. et al., Olive oil, the Mediterranean diet, and arterial blood pressure: The Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am. J. Clin. Nutr. 2004, 80, 1012- 1018.
35. Visioli, F., Poli, A., Richard, D., Paoletti, R., Modulation of inflammation by nutritional interventions. Curr. Atheroscler. Rep. 2008, 10, 451- 453.
36. Papamichael, C. M., Karatzi, K. N., Papaioannou, T. G., Karatzis, E. N. et al., Acute combined effects of olive oil and wine on pressure wave reflections: Another beneficial influence of the Mediterranean diet antioxidants? J. Hypertens. 2008, 26, 223- 229.
37. Ruano, J., Miranda, J. L., Fuentes, F., Moreno, J. A. et al., Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients. J. Am. Coll. Cardiol. 2005, 46, 1864- 1868.
38. Fitó, M., Cladellas, M., de la Torre, R., Martí, J. et al., Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: A randomized, crossover, controlled, clinical trial. Atherosclerosis 2005, 181, 149- 158.
39. Alonso, A., Ruiz-Gutierrez, V., Martínez-González, M. A., Monounsaturated fatty acids, olive oil and blood pressure: Epidemiological, clinical and experimental evidence. Public Health Nutr. 2006, 9, 251- 257.
40. Bogani, P., Galli, C., Villa, M., Visioli, F., Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. Atherosclerosis 2007, 190, 181- 186.
41. Borchert, G. H., Giggey, M., Kolar, F., Wong, T. M. et al., 2-Hydroxyoleic acid affects cardiomyocyte [Ca2+]i transient and contractility in a region-dependent manner. Am. J. Physiol. Heart Circ. Physiol. 2008, 294, 1948- 1955.
42. Panagiotakos, D. B., Pitsavos, C., Arvaniti, F., Stefanadis, C., Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev. Med. 2007, 44, 335- 340.
43. Panagiotakos, D. B., Pitsavos, C., Stefanadis, C., Inclusion of dietary evaluation in cardiovascular disease risk prediction models. increases accuracy and reduces bias of the estimations. Risk Anal. 2009, 29, 176- 186.
44. Visioli, F., Caruso, D., Grande, S., Bosisio, R. et al., Virgin Olive Oil Study (VOLOS): Vasoprotective potential of extra virgin olive oil in mildly dyslipidemic patients. Eur. J. Nutr. 2005, 44, 121- 127.
45. Brzosko, S., De Curtis, A., Murzilli, S., de Gaetano, G. et al., Effect of extra virgin olive oil on experimental thrombosis and primary haemostasis in rats. Nutr. Metab. Cardiovasc. Dis. 2002, 12, 337- 342.
46. Vulin, A. I., Stanley, F. M., Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription. J. Biol. Chem. 2004, 279, 25172- 25178.
47. Bogani, P., Visioli, F., Antioxidants in the Mediterranean diets: An update. World Rev. Nutr. Diet 2007, 97, 162- 169.
48. Lopez-Miranda, J., Delgado-Lista, J., Perez-Martinez, P., Jimenez-Gómez, Y. et al., Olive oil and the haemostatic system. Mol. Nutr. Food Res. 2007, 51, 1249- 1259.
49. Delgado-Lista, J., Lopez-Miranda, J., Cortés, B., Perez-Martinez, P. et al., Chronic dietary fat intake modifies the postprandial response of hemostatic markers to a single fatty test meal. Am. J. Clin. Nutr. 2008, 87, 317- 322.
50. Léger, C. L., Carbonneau, M. A., Michel, F., Mas, E. et al., A thromboxane effect of a hydroxytyrosol-rich olive oil wastewater extract in patients with uncomplicated type I diabetes. Eur. J. Clin. Nutr. 2005, 59, 727- 730.
51. Owen, R. W., Mier, W., Giacosa, A., Hull, W. E. et al., Phenolic compounds and squalene in olive oils: The concentration and antioxidant potential of total phenols, simple phenols, secoroids, lignans and squalene. Food Chem. Toxicol. 2000, 38, 647- 659.
52. Panza, F., Solfrizzi, V., Colacicco, A. M., D'Introno, A. et al., Mediterranean diet and cognitive decline. Public Health Nutr. 2004, 7, 959- 963.
53. Caramia, G., Gli acidi grassi essenziali omega-6 e omega-3: Dalla loro scoperta al loro impiego in terapia. Minerva Pediatr. 2008, 60, 219- 233.
54. Caramia, G., Omega-3: Dall'olio di fegato di merluzzo alla nutrigenomica. Minerva Pediatr. 2008, 60, 443- 455.
55. Sicheri, G., In: Industrie Agrarie e Agroalimentari, Hoepli (Ed.), 4° edizione, Milano (Italy) 2002, pp. 544- 552.
56. Solfrizzi, V., Panza, F., Torres, F., Mastroianni, F. et al., High monounsaturated fatty acids intake protects against age-related cognitive decline. Neurology 1999, 52, 1524- 1530.
57. Agostoni, C., Bresson, J. L., Fairweather-Tait, S., Flynn, A. et al., Scientific Opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage (ID 1333, 1638, 1639, 1696, 2865), maintenance of normal blood HDL-cholesterol concentrations (ID 1639), maintenance of normal blood pressure (ID 3781), "anti-inflammatory properties" (ID 1882), "contributes to the upper respiratory tract health" (ID 3468), "can help to maintain a normal function of gastrointestinal tract" (3779), and "contributes to body defences against external agents" (ID 3467) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA J. 2011, 9, 2033.
58. Carluccio, M. A., Siculella, L., Ancora, M. A., Massaro, M. et al., Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: Antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 622- 629.
59. Cicerale, S., Conlan, X. A., Sinclair, A. J., Keast, R. S., Chemistry and health of olive oil phenolics. Crit. Rev. Food Sci. Nutr. 2009, 49, 218- 236.
60. Fitó, M., Guxens, M., Corella, D., Sáez, G. et al., Effect of a traditional Mediterranean diet on lipoprotein oxidation: A randomized controlled trial. Arch. Intern. Med. 2007, 167, 1195- 1203.
61. Fitó, M., de la Torre, R., Covas, M. I., Olive oil and oxidative stress. Mol. Nutr. Food Res. 2007, 51, 1215- 1224.
62. Holvoet, P., Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh. K Acad. Geneeskd. Belg. 2008, 70, 193- 219.
63. Jialal, I., Fuller, C. J., Huet, B. A., The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study. Arterioscler. Thromb. Vasc. Biol. 1995, 15, 190.
64. Princen, H. M., van Poppel, G., Vogelezang, C., Buytenhek, R., Kok, F. J., Supplementation with vitamin E but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking. Arterioscler. Thromb. 1992, 12, 554- 562.
65. Mazzanti, R., Diet and cancer today: An update. Nutr. Ther. Metabol 2010, 28, 25- 32.
66. Reyes-Zurita, F. J., Rufino-Palomares, E. E., Lupiánez, J. A., Cascante, M., Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer cells via the mitochondrial apoptotic pathway. Cancer Lett. 2009, 273, 44- 54.
67. Caramia, G., Fanos, V., Mediatori lipidici, infezioni e infiammazioni: Evoluzione delle conoscenze e prospettive terapeutiche. Giorn. It. Inf. Ped. 2007, 9, 15- 27.
68. Beauchamp, G. K., Keast, R. S., Morel, D., Lin, J. et al., Phytochemistry: Ibuprofen-like activity in extra-virgin olive oil. Nature 2005, 437, 45- 46.
69. Tuck, K. L., Hayball, P. J., Major phenolic compounds in olive oil: Metabolism and health effects. J. Nutr. Biochem. 2002, 13, 636- 644.
70. Miro-Casas, E., Covas, M. I., Farre, M., Fito, M. et al., Hydroxytyrosol disposition in humans. Clin. Chem. 2003, 49, 945- 952.
71. Hennekens, C. H., Update on aspirin in the treatment and prevention of cardiovascular disease. Am. J. Manag. Care 2002, 8, 691- 700.
72. Lefer, A. M., Müller, H. F., Smith, J. B., Pathophysiological mechanisms of sudden death induced by platelet activating factor. J. Pharmacol. 1984, 83, 125- 130.
73. Hong, Y., Gengo, F. M., Rainka, M. M., Bates, V. E., Mager, D. E., Population pharmacodynamic modelling of aspirin- and Ibuprofen-induced inhibition of platelet aggregation in healthy subjects. Clin. Pharmacokinet. 2008, 47, 129- 137.
74. Harris, R. E., Beebe-Donk, J., Alshafie, G. A., Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 2008, 8, 237.
75. Zhou, Y., Su, Y., Li, B., Liu, F. et al., Non-steroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. Science 2003, 302, 1215- 1217.
76. Imbimbo, B. P., Therapeutic potential of gamma-secretase inhibitors and modulators. Curr. Top Med. Chem. 2008, 8, 54- 61.
77. Togna, G. I., Togna, A. R., Franconi, M., Olive oil isochromans inhibit human platelet reactivity. J. Nutr. 2003, 133, 2532- 2536.
78. Abia, R., Pacheco, Y. M., Perona, J. S., Montero, E. et al., The metabolic availability of dietary triacylglycerols from two high oleic oils during the postprandial period does not depend on the amount of oleic acid ingested by healthy men. J. Nutr. 2001, 131, 59- 65.
79. Amarowicz, R., Squalene: A natural antioxidant? Eur. J. Lipid Sci. Technol. 2009, 111, 411- 412.
80. Bulló, M., Casas-Agustench, P., Amigó-Correig, P., Aranceta, J., Salas-Salvadó, J., Inflammation, obesity and comorbidities: The role of diet. Public Health Nutr. 2007, 10, 1164- 1172.
81. Wozniak, S. E., Gee, L. L., Wachtel, M. S., Frezza, E. E., Adipose tissue: The new endocrine organ? A review article. Dig. Dis. Sci. 2009, 54, 1847- 1856.
82. Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K. et al., Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307, 426- 430.
83. Bulló, M., Garcia-Lorda, P., Peinado-Onsurbe, J., Hernández, M. et al., TNFalpha expression of subcutaneous adipose tissue in obese and morbid obese females: Relationship to adipocyte LPL activity and leptin synthesis. Int. J. Obes. 2002, 26, 652- 658.
84. Bulló, M., Garcia-Lorda, P., Megias, I., Salas-Salvadó, J., Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes. Res. 2003, 11, 525- 531.
85. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., et al., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112, 1796- 1808.
86. Cinti, S., Mitchell, G., Barbatelli, G., Murano, I. et al., Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 2005, 46, 2347- 2355.
87. Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F. et al., Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000, 101, 2149- 2153.
88. Souza, S. C., Palmer, H. J., Kang, Y. H., Yamamoto, M. T. et al., TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes. J. Cell Biochem. 2003, 89, 1077- 1086.
89. Van Hall, G., Steensberg, A., Sacchetti, M., Fischer, C. et al., Interleukin-6 stimulates lipolysis and fat oxidation in humans. J. Clin. Endocrinol. Metab. 2003, 88, 3005- 3010.
90. Bastard, J. P., Maachi, M., Lagathu, C., Kim, M. J. et al., Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 2006, 17, 4- 12.
91. Brunelleschi, S., Bardelli, C., Amoruso, A., Gunella, G. et al., Minor polar compounds extra-virgin olive oil extract (MPC-OOE) inhibits NF-kappa B translocation in human monocyte/macrophages. Pharmacol. Res. 2007, 56, 542- 549.
92. Willett, W. C., Dietary fat and breast cancer. Toxicol. Sci. 1999, 52, 127- 146.
93. Filik, L., Ozyilkan, O., Olive-oil consumption and cancer risk. Eur. J. Clin. Nutr. 2003, 57, 191.
94. Costa, I., Moral, R., Solanas, M., Escrich, E., High-fat corn oil diet promotes the development of high histologic grade rat DMBA induced mammary adenocarcinomas, while high olive oil diet does not. Breast Cancer Res. Treat. 2004, 86, 225- 235.
95. Hamdi, H. K., Castellon, R., Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor. Biochem. Biophys. Res. Commun. 2005, 334, 769- 778.
96. Juan, M. E., Wenzel, U., Ruiz-Gutierrez, V., Daniel, H., Planas, J. M., Olive fruit extracts inhibit proliferation and induce apoptosis in HT-29 human colon cancer cells. J. Nutr. 2006, 136, 2553- 2557.
97. Menendez, J. A., Lupu, R., Mediterranean dietary traditions for the molecular treatment of human cancer: Anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9). Curr. Pharm. Biotechnol. 2006, 7, 495- 502.
98. Menendez, J. A., Papadimitropoulou, A., Vellon, L., Lupu, L., A genomic explanation connecting "Mediterranean diet", olive oil and cancer: Oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells. Eur. J. Cancer. 2006, 42, 2425- 2432.
99. Menendez, J. A., Vazquez-Martin, A., Ortega, F. J., Fernandez-Real, J. M., Fatty acid synthase: Association with insulin resistance, type 2 diabetes, and cancer. Clin. Chem. 2009, 55, 425- 438.
100. Menendez, J. A., Vazquez-Martin, A., Colomer, R., Brunet, J. et al., Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells. BMC Cancer 2007, 7, 80. DOI: 10.1186/1471-2407-7-80.
101. Menendez, J. A., Vazquez-Martin, A., Garcia-Villalba, R., Carrasco-Pancorbo, A. et al., TabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO). BMC Cancer 2008, 8, 377.
102. Menendez, J. A., Vazquez-Martin, A., Oliveras-Ferraros, C., Garcia-Villalba, R. et al., Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: Relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2. Int. J. Oncol. 2009, 34, 43- 451.
103. Gaetani, S., Oveisi, F., Piomelli, D., Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide. Neuropsychopharmacology 2003, 28, 1311- 1316.
104. Fu, J., Gaetani, S., Oveisi, F., Lo, J. et al., Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 2003, 425, 90- 93.
105. Fu, J., Oveisi, F., Gaetani, S., Lin, E., Piomelli, D., Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats. Neuropharmacology 2005, 48, 1147- 1153.
106. LoVerme, J., Gaetani, S., Fu, J., Oveisi, F. et al., Regulation of food intake by oleoylethanolamide CMLS. Cell Mol. Life Sci. 2005, 62, 708- 716.
107. Piomelli, D., The element of surprise. Nat. Med. 2008, 14, 720- 721.
108. Schwartz, G. J., Fu, J., Astarita, G., Li, X. et al., The lipid messenger OEA links dietary fat intake to satiety. Cell Metab. 2008, 8, 281- 288.
109. Fu, J., Dipatrizio, N. V., Guijarro, A., Schwartz, G. J. et al., Sympathetic activity controls fat-induced oleoylethanolamide signaling in small intestine. J. Neurosci. 2011, 31, 5730- 5736.
110. Bookout, A. L., Jeong, Y., Downes, M., Yu, R. T. et al., Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 2006, 126, 789- 799.
111. Fu, J., Kim, J., Oveisi, F., Astarita, G., Piomelli, D., Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295, 45- 50.
112. Nagasawa, M., Akasaka, Y., Ide, T., Hara, T. et al., Highly sensitive upregulation of apolipoprotein A-IV by peroxisome proliferator-activated receptor alpha (PPARalpha) agonist in human hepatoma cells. Biochem. Pharmacol. 2007, 74, 1738- 1746.
113. Gaetani, S., Kaye, W. H., Cuomo, V., Piomelli, D., Role of endocannabinoids and their analogues in obesity and eating disorders. Eat Weight Disord. 2008, 13, 42- 48.
114. Serrano, A., Del Arco, I., Javier, F., Pavón, M. et al., The cannabinoid CB1 receptor antagonist SR 141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats. Neuropharmacology 2008, 54, 226- 234.
115. Pérez-Martínez, P., García-Ríos, A., Delgado-Lista, J., Pérez-Jiménez, F., López-Miranda, J., Mediterranean diet rich in olive oil and obesity, metabolic syndrome and diabetes mellitus. Curr. Pharm. Des. 2011, 17, 769- 777.
116. Konstantinidou, V., Khymenets, O., Fito, M., De La Torre, R. et al., Characterization of human gene expression changes after olive oil ingestion: An exploratory approach. Folia Biol. (Praha) 2009, 55, 85- 91.
117. Khymenets, O., Fito, M., Covas, M. I., Farré, M. et al., Mononuclear cell transcriptome response after sustained virgin olive oil consumption in humans: An exploratory nutrigenomics study. Omics 2009, 13, 7- 19.
118. Konstantinidou, V., Covas, M. I., Muñoz-Aguayo, D., Khymenets, O. et al., In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: A randomized controlled trial. FASEB J. 2010, 24, 2546- 2557.
119. Camargo, A., Ruano, J., Fernandez, J. M., Parnell, L. D. et al., Gene expression changes in mononuclear cells in patients with metabolic syndrome after acute intake of phenol-rich virgin olive oil. BMC Genomics 2010, 20, 253- 264.
120. Oliveras-Ferraros, C., Fernández-Arroyo, S., Vazquez-Martin, A., Lozano-Sánchez, J. et al., Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3. Int. J. Oncol. 2011, 38, 1533- 1547.